Hadizadeh Riseh S, Abbasalizad Farhang M, Mobasseri M, Asghari Jafarabadi M
Tabriz University of Medical Sciences, Student Research Committee, Dept. of Community Nutrition, Tabriz, Iran.
Tabriz University of Medical Sciences, Drug Applied Research Center, Dept. of Community Nutrition, Tabriz, Iran.
Acta Endocrinol (Buchar). 2017 Apr-Jun;13(2):174-179. doi: 10.4183/aeb.2017.174.
Hashimoto's thyroiditis is in coexistence with many autoimmune disorders, especially celiac disease. There are a limited number of studies evaluating the prevalence of celiac-related antibodies in patients with Hashimoto's thyroiditis.
This study aimed to further investigate the prevalence of undiagnosed celiac disease in patients with Hashimoto's thyroiditis and the relationship between these two autoimmune disorders in these patients.
This study was performed on 82 women aged 20-50 years including 40 patients with Hashimoto's thyroiditis and 42 healthy age-matched individuals. Anthropometric assessments were performed and biochemical parameters including thyroid hormones (TSH, T3 and T4), antithyroid antibodies, anti-tissue transglutaminase and anti-gliadin antibodies were measured by enzyme linked immunosorbent assay (ELISA).
The prevalence of IgG and IgA anti-tissue transglutaminase antibodies and IgA anti-gliadin antibody was higher in Hashimoto's thyroiditis patients compared with control group (15% 7%, 22.5% 17% and 15% 12% respectively). In ordinal regression model, serum IgG anti-tissue transglutaminase and IgA anti-gliadin antibodies were significant predictors of antithyroid antibodies in patients with Hashimoto's thyroiditis (P < 0.05). A significant relationship between serum TSH and IgG anti-gliadin antibody were also found (P = 0.003).
To our findings, a high prevalence of anti-tissue transglutaminase and IgA anti-gliadin antibodies and their positive relationship with antithyroid antibodies in patients with Hashimoto's thyroiditis were reported. These findings further warrant the need for interventions to reduce the prevalence of these antibodies in Hashimoto's thyroiditis for preventing the occurrence of celiac disease in these patients.
桥本甲状腺炎常与多种自身免疫性疾病并存,尤其是乳糜泻。评估桥本甲状腺炎患者中乳糜泻相关抗体患病率的研究数量有限。
本研究旨在进一步调查桥本甲状腺炎患者中未诊断出的乳糜泻患病率,以及这两种自身免疫性疾病在这些患者中的关系。
本研究对82名年龄在20至50岁的女性进行,其中包括40例桥本甲状腺炎患者和42名年龄匹配的健康个体。进行了人体测量评估,并通过酶联免疫吸附测定(ELISA)测量了包括甲状腺激素(促甲状腺激素、T3和T4)、抗甲状腺抗体、抗组织转谷氨酰胺酶和抗麦醇溶蛋白抗体在内的生化参数。
与对照组相比,桥本甲状腺炎患者中IgG和IgA抗组织转谷氨酰胺酶抗体以及IgA抗麦醇溶蛋白抗体的患病率更高(分别为15%对7%、22.5%对17%和15%对12%)。在有序回归模型中,血清IgG抗组织转谷氨酰胺酶和IgA抗麦醇溶蛋白抗体是桥本甲状腺炎患者抗甲状腺抗体的重要预测指标(P<0.05)。还发现血清促甲状腺激素与IgG抗麦醇溶蛋白抗体之间存在显著关系(P = 0.003)。
根据我们的研究结果,报告了桥本甲状腺炎患者中抗组织转谷氨酰胺酶和IgA抗麦醇溶蛋白抗体的高患病率及其与抗甲状腺抗体的正相关关系。这些发现进一步证明需要采取干预措施来降低桥本甲状腺炎患者中这些抗体的患病率,以预防这些患者发生乳糜泻。